Elevated ALT With Normal AST: Common Causes and Next Steps

• When ALT is elevated but AST remains normal, the pattern points specifically toward hepatocellular (liver cell) injury without significant extrahepatic involvement, because ALT is far more liver-specific than AST.
• Nonalcoholic fatty liver disease (NAFLD) is the most common cause of isolated or predominant ALT elevation, characteristically producing an ALT level higher than AST (De Ritis ratio less than 1).
• The De Ritis ratio (AST divided by ALT) is a powerful diagnostic tool: a ratio less than 1 suggests NAFLD or viral hepatitis, a ratio of 1-2 is non-specific, and a ratio greater than 2 strongly suggests alcoholic liver disease or cirrhosis.
• Medications including statins, isoniazid, and numerous herbal supplements can cause isolated ALT elevation through direct hepatocellular toxicity.
• A systematic workup including repeat testing, viral hepatitis serology, iron studies, autoimmune markers, and liver imaging can identify the cause in over 90% of cases.

This article was developed through a rigorous review of the following evidence-based sources:

• AASLD (American Association for the Study of Liver Diseases) clinical practice guidance for the evaluation of abnormal liver chemistries and management of NAFLD, viral hepatitis, and drug-induced liver injury.
• MedlinePlus (National Library of Medicine) clinical reference for ALT and AST testing, normal ranges, and clinical interpretation.
• NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) guidance on liver disease evaluation, with emphasis on NAFLD and viral hepatitis.
• UpToDate evidence-based clinical decision support for the approach to patients with abnormal liver biochemical tests.
• Peer-reviewed literature from Hepatology, Journal of Hepatology, Clinical Gastroenterology and Hepatology, and the American Journal of Gastroenterology published between 2020 and 2026.

ALT: The Liver-Specific Enzyme

Alanine aminotransferase (ALT) is an enzyme found predominantly in the cytoplasm of hepatocytes (liver cells). It catalyzes the transfer of an amino group from alanine to alpha-ketoglutarate, producing pyruvate and glutamate. ALT is present in much lower concentrations in the kidneys, heart, and skeletal muscle, making it the most specific serum marker for hepatocellular injury.

Normal ALT values typically range from 7 to 56 U/L, though reference ranges vary between laboratories. Some reference labs and clinical guidelines have proposed lowering the upper limit of normal to account for the fact that traditional ranges may underestimate liver disease in certain populations.

AST: The Less Specific Counterpart

Aspartate aminotransferase (AST) is found in the liver, heart, skeletal muscle, kidneys, brain, pancreas, lungs, and red blood cells. Because of its wide tissue distribution, AST elevation is less specific for liver injury than ALT elevation. AST exists in two isoenzymes: mitochondrial AST (mAST) and cytoplasmic AST (cAST). In mild liver injury, cAST is released, while more severe injury releases mAST as well.

Normal AST values typically range from 10 to 40 U/L.

Why Elevated ALT With Normal AST Is Significant

The combination of elevated ALT with a normal AST is clinically meaningful for several reasons:

1. High liver specificity: Because ALT is far more liver-specific than AST, an isolated ALT elevation is almost always hepatic in origin, whereas isolated AST elevation could originate from the heart, muscle, or other organs.

2. De Ritis ratio implications: The AST-to-ALT ratio (known as the De Ritis ratio) is a well-established diagnostic tool. When ALT exceeds AST (ratio less than 1), the differential diagnosis narrows considerably:

   • NAFLD/NASH: Most common cause; ALT typically exceeds AST
   • Acute viral hepatitis: ALT markedly elevated, often exceeding AST
   • Drug-induced liver injury: Variable, but many agents cause predominant ALT elevation
   • Autoimmune hepatitis: ALT often exceeds AST, especially in early disease

3. Exclusion of alcoholic liver disease: Alcoholic liver disease characteristically produces an AST-to-ALT ratio greater than 2 (due to pyridoxal phosphate depletion reducing ALT synthesis and mitochondrial AST release). A normal AST with elevated ALT essentially excludes alcoholic liver disease as the primary diagnosis.

4. Prognostic information: An AST-to-ALT ratio greater than 1 in the context of chronic liver disease is associated with a higher risk of progression to cirrhosis, making a ratio less than 1 (as seen with elevated ALT and normal AST) generally a more favorable prognostic indicator.

1. Nonalcoholic Fatty Liver Disease (NAFLD)

NAFLD is by far the most common cause of elevated ALT with normal AST. It is characterized by hepatic fat accumulation in the absence of significant alcohol consumption, and it encompasses a spectrum from simple steatosis to nonalcoholic steatohepatitis (NASH) with fibrosis.

Prevalence and risk factors:

• Affects 25-30% of adults in Western countries
• Strongly associated with obesity (present in 60-90% of NAFLD patients)
• Closely linked to type 2 diabetes, hyperlipidemia, and metabolic syndrome
• Increasing prevalence in children and adolescents due to rising obesity rates

Enzyme pattern in NAFLD:

• ALT typically 1-4 times the upper limit of normal
• AST usually normal or lower than ALT (AST-to-ALT ratio less than 1)
• GGT may be mildly elevated
• Alkaline phosphatase usually normal
• Bilirubin typically normal

Why ALT exceeds AST in NAFLD: In NAFLD, the primary mechanism of enzyme elevation is hepatocellular fat accumulation causing oxidative stress and mild inflammation. This process predominantly affects the cytoplasm of hepatocytes where ALT is concentrated, rather than the mitochondria where significant AST resides. The result is a disproportionate ALT elevation compared to AST.

Diagnostic criteria:

• Imaging evidence of hepatic steatosis (ultrasound, CT, or FibroScan)
• Exclusion of significant alcohol consumption (less than 21 drinks/week for men, 14 for women)
• Exclusion of other liver diseases (viral, autoimmune, metabolic)
• Liver biopsy for definitive NASH diagnosis (not always required)

Treatment and outcomes: Weight loss of 7-10% of body weight is the cornerstone of treatment. Pharmacologic options for biopsy-proven NASH include pioglitazone (for insulin resistance and inflammation) and vitamin E (for non-diabetic patients). GLP-1 receptor agonists (semaglutide, tirzepatide) have shown significant benefit in reducing liver fat and inflammation in recent clinical trials.

2. Medication-Induced ALT Elevation

Numerous medications can cause elevated ALT with a normal AST through direct hepatocellular toxicity or idiosyncratic immune-mediated injury.

Statins: Statins (HMG-CoA reductase inhibitors) are the most commonly implicated medications for mild ALT elevation. Key points:

• Mild ALT elevation occurs in 0.5-3% of statin users
• Usually self-limited, normalizing in 70% of cases despite continued use
• AST typically remains normal or is only minimally elevated
• Current guidelines recommend discontinuation only when ALT exceeds 3x ULN
• The cardiovascular benefits of statins overwhelmingly outweigh the hepatic risks
• Routine monitoring of liver enzymes is no longer universally recommended but should be performed when clinically indicated

Isoniazid:

• Used for tuberculosis treatment and prophylaxis
• Causes ALT elevation in 10-20% of patients
• Severe hepatotoxicity in approximately 1% of patients
• AST elevation typically parallels ALT but may lag
• Monthly liver enzyme monitoring is recommended during therapy

Other medications causing predominant ALT elevation:

Herbal and dietary supplements: The growing use of herbal supplements has made them an increasingly recognized cause of liver enzyme elevation. Common hepatotoxic supplements include:

• Green tea extract (high-dose catechins): Can cause significant ALT elevation
• Kava kava: Associated with hepatocellular injury and rare fulminant hepatic failure
• Black cohosh: Reports of hepatotoxicity, though causality debated
• Bodybuilding supplements: Whey protein, creatine, and anabolic precursors can elevate ALT
• Vitamin A (excessive doses): Hepatocellular toxicity with chronic high-dose use
• Weight loss supplements: Multiple agents implicated in liver injury

3. Chronic Viral Hepatitis (Early or Mild Disease)

In the early stages of chronic hepatitis B or C, ALT may be elevated while AST remains within the normal range.

Hepatitis C:

• Chronic HCV infection often causes fluctuating ALT levels
• ALT may be the only elevated enzyme in early or mild chronic infection
• The ALT level does not reliably predict the degree of liver fibrosis
• Anti-HCV antibody with confirmatory HCV RNA is diagnostic
• Direct-acting antiviral (DAA) therapy cures more than 95% of cases

Hepatitis B:

• Chronic HBV can present with isolated ALT elevation, particularly during immune-active phases
• HBsAg and HBV DNA testing are essential for diagnosis and treatment decisions
• Treatment with entecavir or tenofovir effectively suppresses viral replication
• ALT normalization is a treatment response marker

4. Autoimmune Hepatitis (Early Presentation)

Autoimmune hepatitis (AIH) can present with an elevated ALT and a normal AST, particularly in its early or mild stages.

Key characteristics:

• Female predominance (80% of cases)
• Often presents in young to middle-aged women
• Associated with other autoimmune conditions (thyroiditis, ulcerative colitis, rheumatoid arthritis)
• ANA (anti-nuclear antibody) positive in approximately 80% of type 1 AIH
• Anti-smooth muscle antibody (ASMA) positive in approximately 70% of cases
• Elevated IgG levels (non-specific but supportive)
• ALT typically exceeds AST in early disease; the ratio may equalize or reverse as disease progresses

5. Hemochromatosis and Metabolic Liver Disease

Hereditary hemochromatosis (HFE-related) can cause isolated or predominant ALT elevation in its early stages before significant iron overload has occurred.

Key features:

• Most common genetic liver disease in people of Northern European descent
• C282Y homozygosity is the primary genetic mutation
• Elevated ferritin (greater than 300 ng/mL in men, greater than 200 ng/mL in women) and transferrin saturation (greater than 45%)
• ALT elevation often mild (1-2x ULN) in early disease
• AST typically normal until significant hepatic iron deposition occurs
• Treatment with therapeutic phlebotomy prevents disease progression

6. Celiac Disease

Celiac disease is an often-overlooked cause of mild ALT elevation with a normal AST. Studies have found that up to 40% of untreated celiac disease patients have mildly elevated liver enzymes, with ALT being the most commonly affected.

Key points:

• ALT elevation is usually mild (1-2x ULN)
• AST typically remains within the normal range
• Liver enzymes normalize in 75-95% of patients within 6-12 months of starting a gluten-free diet
• Tissue transglutaminase IgA (tTG-IgA) is the recommended screening test
• The mechanism is thought to involve increased intestinal permeability and immune-mediated hepatic inflammation

7. Thyroid Disorders

Both hyperthyroidism and hypothyroidism can cause mild ALT elevation with a normal AST.

• Hyperthyroidism: Increases hepatic oxygen demand and causes relative ischemia; ALT elevation is more common than AST elevation.
• Hypothyroidism: Reduces hepatic blood flow and impairs lipid metabolism, leading to steatosis and mild ALT elevation.
• In both conditions, liver enzymes typically normalize with treatment of the thyroid disorder.
• TSH screening is recommended in the evaluation of unexplained mild ALT elevation.

The AST-to-ALT ratio, known as the De Ritis ratio (named after Fernando De Ritis, who described its clinical significance in 1957), is one of the most useful tools for interpreting liver enzyme patterns.

Interpreting the Ratio

Why Elevated ALT With Normal AST Produces a Low Ratio

When ALT is elevated and AST is normal, the De Ritis ratio is less than 1. This pattern is characteristic of conditions that primarily affect hepatocyte cytoplasm (where ALT resides) rather than mitochondria (where significant AST is found). It also indicates that pyridoxal phosphate (vitamin B6) availability is not depleted, as it is in alcoholic liver disease.

This ratio is one of the strongest arguments against alcoholic liver disease as the cause of liver enzyme elevation. If the ratio is less than 1, the clinician should focus on NAFLD, viral hepatitis, medication effects, and autoimmune conditions.

Step 1: Confirm the Finding (Repeat Testing)

As with any abnormal liver test, the first step is to repeat the liver panel after 2-4 weeks. During this interval, avoid alcohol, strenuous exercise, and unnecessary medications or supplements. If the repeat test shows:

• Normal ALT: The elevation was transient; no further workup needed unless clinical suspicion warrants it.
• Persistent ALT elevation: Proceed to systematic evaluation.

Step 2: Targeted History and Physical Examination

A focused history should address:

• Alcohol use: Detailed quantity and frequency (AUDIT questionnaire). Even if AST is normal, alcohol can contribute to liver enzyme elevation.
• Medications and supplements: Complete list including over-the-counter drugs, herbal products, and dietary supplements.
• Metabolic risk factors: BMI, waist circumference, diabetes status, lipid profile, physical activity level.
• Viral hepatitis risk factors: Blood transfusions, IV drug use, sexual contacts, tattoos, body piercing, occupational exposures, travel to endemic areas.
• Family history: Liver disease, hemochromatosis, autoimmune conditions, early-onset liver failure.
• Symptoms: Fatigue, right upper quadrant discomfort, jaundice, pruritus, dark urine, pale stools, arthralgias, rash.

Physical examination should assess for:

• Hepatomegaly, splenomegaly
• Signs of chronic liver disease: spider angiomata, palmar erythema, gynecomastia, testicular atrophy, ascites, caput medusae
• Body habitus: BMI, waist circumference, acanthosis nigricans (insulin resistance marker)

Step 3: Laboratory Evaluation

Step 4: Imaging

Step 5: Specialty Referral

Refer to a hepatologist or gastroenterologist when:

• The cause of elevated ALT with normal AST remains unclear after basic workup.
• FibroScan shows significant fibrosis (liver stiffness greater than 8 kPa).
• Autoimmune markers are positive.
• There is a family history of genetic liver disease with positive screening tests.
• ALT elevation is progressive or exceeds 2x ULN persistently.

What does elevated ALT with normal AST mean?

Elevated ALT with a normal AST most commonly indicates mild hepatocellular (liver cell) injury from a condition that primarily affects liver cell cytoplasm. Because ALT is more liver-specific than AST, this pattern narrows the differential diagnosis toward conditions like nonalcoholic fatty liver disease (NAFLD), medication effects, early chronic viral hepatitis, and autoimmune hepatitis. The normal AST makes alcoholic liver disease very unlikely, as alcoholic liver disease typically produces an AST level that is at least twice the ALT level.

Is elevated ALT with normal AST dangerous?

In most cases, no. Elevated ALT with normal AST is usually a sign of mild, early, or slowly progressive liver disease rather than acute severe injury. The most common cause is NAFLD, which in its simple steatosis form does not progress to serious liver disease in the majority of patients. However, persistent elevation should not be ignored, as it may indicate an underlying condition that could progress if left untreated. The degree of danger depends on the underlying cause, the level of ALT elevation, and the presence of fibrosis on imaging or biopsy.

Can medications cause elevated ALT with normal AST?

Yes. Medications are one of the most common causes of this pattern. Statins (cholesterol-lowering medications) frequently cause mild ALT elevation while AST remains normal. Other medications that can produce this pattern include isoniazid (for tuberculosis), nitrofurantoin (antibiotic), valproic acid (anticonvulsant), terbinafine (antifungal), and numerous herbal and dietary supplements. If your healthcare provider suspects a medication is causing elevated ALT, they may recommend monitoring, dose adjustment, or switching to an alternative medication.

How is elevated ALT with normal AST different from when both are elevated?

The key difference lies in the diagnostic implications. When only ALT is elevated with a normal AST, the differential diagnosis favors conditions that primarily release cytoplasmic liver enzymes, such as NAFLD, early viral hepatitis, and medication effects. When both ALT and AST are elevated, the differential broadens to include more causes of hepatocellular injury, and the AST-to-ALT ratio (De Ritis ratio) becomes an important diagnostic tool. A normal AST essentially excludes alcoholic liver disease and makes advanced cirrhosis less likely.

What tests should be done for elevated ALT with normal AST?

The recommended evaluation for persistent elevated ALT with normal AST includes:

1. Repeat liver panel to confirm the elevation persists.
2. Hepatitis B and C serology to screen for chronic viral hepatitis.
3. Iron studies (ferritin and transferrin saturation) to screen for hemochromatosis.
4. Autoimmune markers (ANA, ASMA) to screen for autoimmune hepatitis.
5. TSH to screen for thyroid disease.
6. Metabolic assessment (lipid profile, HbA1c, fasting glucose) for NAFLD risk factors.
7. Abdominal ultrasound to evaluate liver parenchyma, steatosis, and focal lesions.
8. FibroScan (if available) to assess for fibrosis and steatosis non-invasively. Additional tests such as ceruloplasmin (Wilson disease), tTG-IgA (celiac disease), and GGT may be ordered based on clinical suspicion.

Can exercise cause elevated ALT with normal AST?

Exercise can elevate both AST and ALT, but the pattern typically shows AST elevated more than ALT (because AST is abundant in skeletal muscle). Isolated ALT elevation from exercise alone is less common but can occur, particularly with endurance training and weightlifting that involves significant core and abdominal muscle engagement. If exercise is suspected as the cause, repeat testing after 5-7 days of rest from strenuous activity can clarify whether the elevation is exercise-related. If enzymes normalize with rest, no further liver evaluation is necessary.

Elevated ALT with a normal AST is a common and clinically significant laboratory pattern that strongly suggests hepatocellular injury from a limited set of causes. NAFLD is by far the most common explanation, particularly in patients with metabolic risk factors. Medication effects, chronic viral hepatitis, autoimmune hepatitis, and metabolic liver diseases round out the differential diagnosis.

The De Ritis ratio (AST-to-ALT ratio) provides powerful diagnostic information when ALT exceeds AST: a ratio less than 1 effectively excludes alcoholic liver disease and points toward NAFLD, viral hepatitis, or drug-induced injury as the primary consideration.

The diagnostic approach should be systematic: confirm the abnormality with repeat testing, perform targeted serology and metabolic screening, obtain liver imaging, and refer to a specialist when the cause remains unclear or when there is evidence of progressive disease. For the majority of patients, the cause is identifiable through a thoughtful, stepwise evaluation, and most underlying conditions are treatable with lifestyle modification, medication adjustment, or disease-specific therapy.

This article was last reviewed and updated on April 5, 2026. Clinical practice guidelines are updated regularly; always consult current guidelines and your healthcare provider for the most up-to-date evaluation and management recommendations.